Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has informed that one of the Company’s wholly-owned subsidiaries has voluntarily requested the USFDA to withdraw approval for 28 Abbreviated New Drug Applications (ANDAs). These older drug products belong to erstwhile Ranbaxy Laboratories and are not being marketed in the US since 2008.

The above information is a part of company’s filings submitted to BSE.